Abstract
Chondromyxoid fibroma is a rare, benign tumor of the bone with excellent prognosis but a high rate of recurrence. We report a patient presenting with pain and a history of chondromyxoid fibroma of the distal left femur previously treated with multiple prior curettage and bone graft procedures. Magnetic resonance imaging and histopathology indicated a recurrence of tumor. Due to the small size of the tumor recurrence and challenges associated with prior open surgery, the patient underwent cryoablation of the lesion with computed tomography guidance. Follow-up 18 months later indicated a resolution of pain and improvement on magnetic resonance imaging, and no concerns after 20 months. To our knowledge, this is the first reported case of chondromyxoid fibroma treated with cryoablation. This case suggests cryoablation could be considered in the setting of recurrent chondromyxoid fibroma for local tumor control.
Similar content being viewed by others
Change history
26 August 2023
A Correction to this paper has been published: https://doi.org/10.1007/s00256-023-04429-x
References
Jaffe HL, Lichtenstein L. Chondromyxoid fibroma of bone; a distinctive benign tumor likely to be mistaken especially for chondrosarcoma. Arch Pathol. 1948;45(4):541–51.
Tu WC, Inwards CY, O’laughlin S, Rock MG, Beabout JW, Unni KK. Chondromyxoid fibroma of bone: a clinicopathologic review of 278 cases. Hum Pathol. 1998;29(5):438–46.
Heck RK, Toy PC, et al. Benign/aggressive tumors of bone. In: Azar FM, Beaty JH, et al., editors. Campbell’s Operative Orthopaedics. 13th ed. Philadelphia: Elsevier; 2017. p. 923–44.e3.
Cappelle S, Pans S, Sciot R. Imaging features of chondromyxoid fibroma: report of 15 cases and literature review. Br J Radiol. 2016;89(1064):20160088.
Yalniz E, Alicioglu B, Yalcin O, Yilmaz B. Non specific magnetic resonance features of chondromyxoid fibroma of the iliac bone. Journal of BU ON. 2007;12(3):407–9.
Mitchell M, Sartoris DJ, Resnick D. Case report 713. Chondromyxoid fibroma of the third metatarsal. Skeletal Radiol. 1992;21(4):252–5.
Layfield LJ. Cytopathology of bone and soft tissue tumors. Oxford: Oxford Univ. Press; 2002.
Damle RP, Suryawanshi KH, Dravid NV, Gadre A, Borse YM. Chondromyxoid fibroma of bone. Journal of Case Reports. 2013;3(2):228–31.
Schajowicz F, Gallardo H. Chondromyxoid fibroma (fibromyxoid chondroma) of bone. A clinico-pathological study of thirty-two cases. J Bone and Joint Surg Br Vol. 1971;53(2):198–216.
Rahimi A, Beabout JW, Ivins JC, Dahlin DC. Chondromyxoid fibroma: a clinicopathologic study of 76 cases. Cancer. 1972;30(3):726–36.
Horstmann PF, Hettwer WH, Petersen MM. Treatment of benign and borderline bone tumors with combined curettage and bone defect reconstruction. J Orthop Surg. 2018;26(3):2309499018774929.
Berenstein-Weyel T, Lebel E, Katz D, Applbaum Y, Peyser A. Chondromyxoid fibroma of the distal fibula treated by percutaneous radiofrequency ablation. J Orthop Surg. 2017;25(2):2309499017720830.
Foster RCB, Stavas JM. Bone and soft tissue ablation. Semin Interv Radiol. 2014;31(2):167–79.
Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208.
Tomasian A, Cazzato RL, Sharma K, Gangi A, Jennings JW. Benign bone tumors: state of the art in minimally invasive percutaneous interventions. Radiographics. 2023;43(2):e220041.
Le Corroller T, Vives T, Mattei J, Pauly V, Guenoun D, Rochwerger A, et al. Osteoid osteoma: percutaneous CT-guided cryoablation is a safe, effective, and durable treatment option in adults. Radiology. 2022;302(2):392–9.
Colangeli S, Parchi P, Andreani L, Beltrami G, Scoccianti G, Sacchetti F, et al. Cryotherapy efficacy and safety as local therapy in surgical treatment of musculoskeletal tumours. A retrospective case series of 143 patients. J Biol Regul Homeost Agents. 2018;32(6 Suppl. 1):65–70.
Fritz J, Sonnow L, Morris CD. Adjuvant MRI-guided percutaneous cryoablation treatment for aneurysmal bone cyst. Skeletal Radiol. 2019;48(7):1149–53.
Zivin SP, Gaba RC. Technical and practical considerations for device selection in locoregional ablative therapy. Semin Interv Radiol. 2014;31(2):212–24.
Callstrom M, Kurup A. Percutaneous ablation for bone and soft tissue metastases—why cryoablation? Skeletal Radiol. 2009;38(9):835–9.
Auloge P, Cazzato RL, Rousseau C, Caudrelier J, Koch G, Rao P, et al. Complications of percutaneous bone tumor cryoablation: a 10-year experience. Radiology. 2019;291(2):521–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original version of this article was revised due to the incorrect affiliation of John M. Gross. The Publisher regrets this error.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gowda, P.C., Dunlap, R.H., Ahlawat, S. et al. Recurrent chondromyxoid fibroma of the distal femur treated with percutaneous cryoablation. Skeletal Radiol 52, 2497–2501 (2023). https://doi.org/10.1007/s00256-023-04414-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-023-04414-4